Squamous nonsmall cell lung cancer therapeutics market 38 24marketreports

Page 1

Report Title:

Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Report 2018 Published On: January 2018

Category: Life Sciences

Pages: 110

Report Overview: In this report, the global Squamous NonSmall Cell Lung Cancer Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales K Pcs, revenue Million USD, market share and growth rate of Squamous NonSmall Cell Lung Cancer Therapeutics for these regions, from 2013 to 2025 forecast, covering United States China Europe Japan Southeast Asia India Global Squamous NonSmall Cell Lung Cancer Therapeutics market competition by top manufacturers/players, with Squamous NonSmall Cell Lung Cancer Therapeutics sales volume, Price USD/Pcs, revenue Million USD and market share for each manufacturer/player; the top players including Ascenta Therapeutics, Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG BIND Therapeutics, Inc. Boehringer Ingelheim GmbH BristolMyers Squibb Company Eli Lilly and Company F. HoffmannLa Roche Ltd. Five Prime Therapeutics, Inc.

24marketreports | International +1 646 781 7170 | www.24marketreports.com


Genentech, Inc. Incyte Corporation Johnson & Johnson MacroGenics, Inc. Novartis AG Oncogenex Pharmaceuticals, Inc. PsiOxus Therapeutics Limited On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into BMS906024 Buparlisib Hydrochloride FP1039 Ipilimumab JNJ42756493 Lenvatinib Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Research Center Hospital Clinic If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents: Table of Contents Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Market Report 2018 1 Squamous NonSmall Cell Lung Cancer Therapeutics Market Overview 1.1 Product Overview and Scope of Squamous NonSmall Cell Lung Cancer Therapeutics 1.2 Classification of Squamous NonSmall Cell Lung Cancer Therapeutics by Product Category 1.2.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market Size Sales Comparison by Type 20132025 1.2.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market Size Sales Market Share by Type Product Category in 2017 1.2.3 BMS906024

24marketreports | International +1 646 781 7170 | www.24marketreports.com


1.2.4 Buparlisib Hydrochloride 1.2.5 FP1039 1.2.6 Ipilimumab 1.2.7 JNJ42756493 1.2.8 Lenvatinib 1.2.9 Others 1.3 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market by Application/End Users 1.3.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share Comparison by Application 20132025 1.3.2 Research Center 1.3.3 Hospital 1.3.4 Clinic 1.4 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market by Region 1.4.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market Size Value Comparison by Region 20132025 1.4.2 United States Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.4.3 China Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.4.4 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.4.5 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.4.6 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.4.7 India Squamous NonSmall Cell Lung Cancer Therapeutics Status and Prospect 20132025 1.5 Global Market Size Value and Volume of Squamous NonSmall Cell Lung Cancer Therapeutics 20132025 1.5.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132025 1.5.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132025 2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Competition by Players/Suppliers, Type and Application 2.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market Competition by Players/Suppliers 2.1.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Market Share of Key Players/Suppliers 20132018 2.1.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Share by Players/Suppliers 20132018 2.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Volume and Value by Type 2.2.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Market Share by Type 20132018 2.2.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Market Share

24marketreports | International +1 646 781 7170 | www.24marketreports.com


by Type 20132018 2.3 Global Squamous NonSmall Cell Lung Cancer Therapeutics Volume and Value by Region 2.3.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Market Share by Region 20132018 2.3.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Market Share by Region 20132018 2.4 Global Squamous NonSmall Cell Lung Cancer Therapeutics Volume by Application 3 United States Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 3.1 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 3.1.1 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 3.1.2 United States Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 3.1.3 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018 3.2 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players 20132018 3.3 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 3.4 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 4 China Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 4.1 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 4.1.1 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 4.1.2 China Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 4.1.3 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018 4.2 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players 20132018 4.3 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 4.4 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 5 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 5.1 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 5.1.1 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 5.1.2 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 5.1.3 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018

24marketreports | International +1 646 781 7170 | www.24marketreports.com


5.2 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players 20132018 5.3 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 5.4 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 6 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 6.1 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 6.1.1 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 6.1.2 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 6.1.3 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018 6.2 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players 20132018 6.3 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 6.4 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 7 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 7.1 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 7.1.1 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 7.1.2 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 7.1.3 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018 7.2 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Players 20132018 7.3 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 7.4 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 8 India Squamous NonSmall Cell Lung Cancer Therapeutics Volume, Value and Sales Price 8.1 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Value 20132018 8.1.1 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales and Growth Rate 20132018 8.1.2 India Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate 20132018 8.1.3 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales Price Trend 20132018 8.2 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share

24marketreports | International +1 646 781 7170 | www.24marketreports.com


by Players 20132018 8.3 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Type 20132018 8.4 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Market Share by Application 20132018 9 Global Squamous NonSmall Cell Lung Cancer Therapeutics Players/Suppliers Profiles and Sales Data 9.1 Ascenta Therapeutics, Inc. 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.1.2.1 Product A 9.1.2.2 Product B 9.1.3 Ascenta Therapeutics, Inc. Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.1.4 Main Business/Business Overview 9.2 AstraZeneca Plc 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.2.2.1 Product A 9.2.2.2 Product B 9.2.3 AstraZeneca Plc Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.2.4 Main Business/Business Overview 9.3 AVEO Pharmaceuticals, Inc. 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.3.2.1 Product A 9.3.2.2 Product B 9.3.3 AVEO Pharmaceuticals, Inc. Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.3.4 Main Business/Business Overview 9.4 Bayer AG 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.4.2.1 Product A 9.4.2.2 Product B 9.4.3 Bayer AG Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.4.4 Main Business/Business Overview 9.5 BIND Therapeutics, Inc. 9.5.1 Company Basic Information, Manufacturing Base and Competitors

24marketreports | International +1 646 781 7170 | www.24marketreports.com


9.5.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.5.2.1 Product A 9.5.2.2 Product B 9.5.3 BIND Therapeutics, Inc. Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.5.4 Main Business/Business Overview 9.6 Boehringer Ingelheim GmbH 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.6.2.1 Product A 9.6.2.2 Product B 9.6.3 Boehringer Ingelheim GmbH Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.6.4 Main Business/Business Overview 9.7 BristolMyers Squibb Company 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.7.2.1 Product A 9.7.2.2 Product B 9.7.3 BristolMyers Squibb Company Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.7.4 Main Business/Business Overview 9.8 Eli Lilly and Company 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.8.2.1 Product A 9.8.2.2 Product B 9.8.3 Eli Lilly and Company Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.8.4 Main Business/Business Overview 9.9 F. HoffmannLa Roche Ltd. 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and Specification 9.9.2.1 Product A 9.9.2.2 Product B 9.9.3 F. HoffmannLa Roche Ltd. Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.9.4 Main Business/Business Overview 9.10 Five Prime Therapeutics, Inc. 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Squamous NonSmall Cell Lung Cancer Therapeutics Product Category, Application and

24marketreports | International +1 646 781 7170 | www.24marketreports.com


Specification 9.10.2.1 Product A 9.10.2.2 Product B 9.10.3 Five Prime Therapeutics, Inc. Squamous NonSmall Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 20132018 9.10.4 Main Business/Business Overview 9.11 Genentech, Inc. 9.12 Incyte Corporation 9.13 Johnson & Johnson 9.14 MacroGenics, Inc. 9.15 Novartis AG 9.16 Oncogenex Pharmaceuticals, Inc. 9.17 PsiOxus Therapeutics Limited 10 Squamous NonSmall Cell Lung Cancer Therapeutics Maufacturing Cost Analysis 10.1 Squamous NonSmall Cell Lung Cancer Therapeutics Key Raw Materials Analysis 10.1.1 Key Raw Materials 10.1.2 Price Trend of Key Raw Materials 10.1.3 Key Suppliers of Raw Materials 10.1.4 Market Concentration Rate of Raw Materials 10.2 Proportion of Manufacturing Cost Structure 10.2.1 Raw Materials 10.2.2 Labor Cost 10.2.3 Manufacturing Process Analysis of Squamous NonSmall Cell Lung Cancer Therapeutics 10.3 Manufacturing Process Analysis of Squamous NonSmall Cell Lung Cancer Therapeutics 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 11.1 Squamous NonSmall Cell Lung Cancer Therapeutics Industrial Chain Analysis 11.2 Upstream Raw Materials Sourcing 11.3 Raw Materials Sources of Squamous NonSmall Cell Lung Cancer Therapeutics Major Manufacturers in 2017 11.4 Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk

24marketreports | International +1 646 781 7170 | www.24marketreports.com


13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change 14 Global Squamous NonSmall Cell Lung Cancer Therapeutics Market Forecast 20182025 14.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Price Forecast 20182025 14.1.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Growth Rate Forecast 20182025 14.1.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast 20182025 14.1.3 Global Squamous NonSmall Cell Lung Cancer Therapeutics Price and Trend Forecast 20182025 14.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region 20182025 14.2.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume and Growth Rate Forecast by Regions 20182025 14.2.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast by Regions 20182025 14.2.3 United States Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.2.4 China Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.2.5 Europe Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.2.6 Japan Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.2.7 Southeast Asia Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.2.8 India Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Growth Rate Forecast 20182025 14.3 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume, Revenue and Price Forecast by Type 20182025 14.3.1 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Forecast by Type 20182025 14.3.2 Global Squamous NonSmall Cell Lung Cancer Therapeutics Revenue Forecast by Type 20182025 14.3.3 Global Squamous NonSmall Cell Lung Cancer Therapeutics Price Forecast by Type 20182025 14.4 Global Squamous NonSmall Cell Lung Cancer Therapeutics Sales Volume Forecast by Application 20182025 15 Research Findings and Conclusion 16 Appendix

24marketreports | International +1 646 781 7170 | www.24marketreports.com


16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer

Get More Information about the Report: Report URL: https://www.24marketreports.com/life-sciences/squamous-nonsmall-cell-lung-cancer-therapeuti cs-market-38 To get Report Sample: https://www.24marketreports.com/request-sample/squamous-nonsmall-cell-lung-cancer-therap eutics-market-38

24marketreports | International +1 646 781 7170 | www.24marketreports.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.